In their Nature Medicine statement.
Advance in K-Ras-mutated cancer research A team of cancer researchers from several Boston academic medical centers has discovered a potential treatment for a group of tumors which have resisted previous targeted therapy approaches. In their Nature Medicine statement, which receives early online launch, investigators from Dana-Farber Malignancy Institute , Massachusetts General Hospital Cancer Center, and Beth Israel Deaconess Medical Center Cancer Center report that combining two different kinase inhibitors – drugs that hinder specific cell-growth pathways – resulted in significant tumor shrinkage in mice with lung cancers powered by mutations in the K-Ras gene.The most crucial lesson is that incentives work. This pressure exists almost everywhere but is specially intense in China. It is consequently no surprise that the most inventive ways to game the peer-review system to get manuscripts published have come from China. The firms mentioned above offering fake peer testimonials all result from China and countries in Southeast Asia, and most of the authors involved in these full cases result from the same areas. But it would be a mistake to check out this as a Chinese or Asian problem. The nagging problem is the perverse incentive systems in scientific publishing.